Loss-of-function mutations in CARD14 are associated with a severe variant of atopic dermatitis

Atopic Dermatitis

Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis

JAMA Dermatol.

Margolis DJ, Mitra N, Wubbenhorst B, D'Andrea K, Kraya AA, Hoffstad O, Shah S, Nathanson KL

doi: 10.1001/jamadermatol.2019.1946.

RECOMMENDED

Allergic Diseases

Filaggrin loss of function mutations are a factor in patients with multiple contact allergies

Contact Dermatitis.

Elhaji Y, Sasseville D, Pratt M, Asai Y, Matheson K, McLean WHI, Hull P

doi: 10.1111/cod.13268.

Atopic Dermatitis

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

JAMA Dermatol.

Simpson EL, Guttman-Yassky E, Margolis DJ, Feldman SR, Qureshi A, Hata T, Mastey V, Wei W, Eckert L, Chao J, Arnold RJG, Yu T, Vekeman F, Suárez-Fariñas M, Gadkari A

doi: 10.1001/jamadermatol.2018.

Atopic Dermatitis

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life, and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomised trial

J Eur Acad Dermatol Venereol

Wollenberg A, Nakahara T, Maari C, Peris K, Lio P, Augustin M, Silverberg JI, Rueda MJ, DeLozier AM, Pierce E, Yang FE, Sun L, Ball S, Tauber M, Paul C

doi: 10.1111/jdv.17278

Atopic Dermatitis

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

JAMA Dermatol.

Thorsteinsdottir S, Stokholm J, Thyssen JP, Nørgaard S, Thorsen J, Chawes BL, Bønnelykke K, Waage J, Bisgaard H

doi: 10.1001/jamadermatol.

Atopic Dermatitis

Increasing Severity of Early-Onset Atopic Dermatitis, But Not Late-Onset, Associates with Development of Aeroallergen Sensitization and Allergic Rhinitis in Childhood

Allergy

Schoos AM, Chawes BL, Bønnelykke K, Stokholm J, Rasmussen MA, Bisgaard H

doi: 10.1111/all.15108

COMMENTED

Atopic Dermatitis

The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study

Br J Dermatol.

Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, Song T, Pavel AB, Guttman-Yassky E

doi: 10.1111/bjd.17932.

Atopic Dermatitis

Dupilumab for Moderate-to-Severe Atopic Dermatitis

Skin Therapy Lett.

Vangipuram R, Tyring SK

Atopic Dermatitis

Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study

J Am Acad Dermatol.

Fishbein AB, Mueller K, Kruse L, Boor P, Sheldon S, Zee P, Paller AS

doi: 10.1016/j.jaad.2017.08.043.

Related content

Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis

Filaggrin loss of function mutations are a factor in patients with multiple contact allergies

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life, and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomised trial

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

Increasing Severity of Early-Onset Atopic Dermatitis, But Not Late-Onset, Associates with Development of Aeroallergen Sensitization and Allergic Rhinitis in Childhood

The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study

Dupilumab for Moderate-to-Severe Atopic Dermatitis

Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study